Macular Deep Capillary Plexus Ischemia as a Biomarker for Identifying Referable Diabetic Retinopathy
Investigative Ophthalmology & Visual Science · 2025
DOI: 10.1167/iovs.66.14.45 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2025. Written by Shinji Kakihara and 2 co-authors. Institution: Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States. Major MEDLINE topics: Diabetic Retinopathy, Retinal Vessels, Ischemia, Macula Lutea. Cited 9 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NIH HHS, NEI NIH HHS.
Abstract (original language)
Purpose
To evaluate deep capillary plexus (DCP) ischemia measured on 3 × 3-mm macular optical coherence tomography angiography (OCTA) as a biomarker for referable diabetic retinopathy (refDR).
Methods
In this cross-sectional study, we analyzed 290 eyes from 193 patients with diabetes and varying severity but without macular edema. Averaged macular OCTA images were processed to calculate a range of OCTA metrics, including geometric perfusion deficits (GPDs). Each OCTA metric was evaluated for its ability to discriminate refDR using (1) an OCTA-only generalized estimating equation logistic model and (2) a model combining the metric with clinical covariates (age, sex, diabetes duration, hemoglobin A1c, and hypertension). Accuracy was quantified by the area under the curve (AUC), and model-to-model differences (ΔAUC) were evaluated using 1000-iteration cluster-bootstrap resampling. Internal validity and calibration of the best-performing OCTA-only model were assessed using subject-wise fivefold cross-validation and the Brier score.
Results
Among 10 OCTA metrics, GPDs in the DCP (GPD-DCP) achieved the highest standalone discrimination (AUC = 0.913; 95% confidence interval, 0.879-0.947) and significantly improved the model with clinical covariates (AUC increase from 0.865 to 0.934; ΔAUC = +0.070; P = 0.002). At clinically relevant thresholds, GPD-DCP achieved 95% sensitivity with 63.5% specificity, as well as 95% specificity with 63.2% sensitivity. Subject-wise cross-validation confirmed robust performance (mean [SD] AUC = 0.919 [0.034]), with excellent calibration (Brier score = 0.115).
Conclusions
GPD-DCP offers excellent, well-calibrated discrimination of refDR and significantly improves risk stratification when combined with standard clinical factors, supporting its use for screening and risk assessment.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States.
Funding
- NIH HHS
- NEI NIH HHS
Cite
APA
Kakihara, S., Zhuang, K., & Fawzi, A. A. (2025). Macular Deep Capillary Plexus Ischemia as a Biomarker for Identifying Referable Diabetic Retinopathy. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.14.45
Vancouver
Kakihara S, Zhuang K, Fawzi AA. Macular Deep Capillary Plexus Ischemia as a Biomarker for Identifying Referable Diabetic Retinopathy. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.14.45
BibTeX
@article{Kakihara2025,
author = {Kakihara, Shinji and Zhuang, Kallista and Fawzi, Amani A},
title = {Macular Deep Capillary Plexus Ischemia as a Biomarker for Identifying Referable Diabetic Retinopathy},
journal = {Investigative Ophthalmology & Visual Science},
year = {2025},
doi = {10.1167/iovs.66.14.45}
}
EUVIMED